The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled ...
Just as the pressure to cut prices is building, a new strategy has emerged to help mitigate risk: breakthrough status. Last July, the FDA introduced a new process to speed up approvals for ...
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.